CAN
YARW

Cetera Advisor Networks’s Yarrow Bioscience YARW Stock Holding History

Cetera Advisor Networks’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-128
Closed -$17.3K – 2679
2022
Q4 		$17.3K Hold
128
– – ﹤0.01% 2492
2022
Q3 		$26K Hold
128
– – ﹤0.01% 2042
2022
Q2 		$45K Buy
+128
New +$53.7K ﹤0.01% 2007
2020
Q3 		– Hold
0
– -$3K – 2990
2020
Q2 		– Hold
0
– – – 3172

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Cetera Advisor Networks's YARW Position: Q1 2023 in Review

Cetera Advisor Networks sold out of Yarrow Bioscience (YARW) in Q1 2023, closing a stake of 128 shares — an estimated $17.3K sold.

Cetera Advisor Networks first reported a position in YARW in Q2 2022 and held it in 3 quarters. The position peaked at $45K in Q2 2022. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

  • Cetera Advisor Networks reported no remaining Yarrow Bioscience position as of Q1 2023 after selling out during the quarter.
  • Cetera Advisor Networks sold 128 Yarrow Bioscience shares in Q1 2023, an estimated $17.3K.
  • Cetera Advisor Networks first reported a position in Yarrow Bioscience in Q2 2022 and held it in 3 quarters.
  • Cetera Advisor Networks's Yarrow Bioscience position peaked at $45K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2023.

Based on Cetera Advisor Networks's 13F filing for Q1 2023, filed 15 May 2023.